| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/27/2009 | US20090214678 Herbal Formulation for the Prevention and Management of Diabetes Mellitus and Diabetic Micro-Vascular Complications |
| 08/27/2009 | US20090214637 Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity |
| 08/27/2009 | US20090214565 Anti-Interferon Alpha Monoclonal Antibodies and Methods For Use |
| 08/27/2009 | US20090214514 Gus3 neuropeptides for regulating hypothalamic function |
| 08/27/2009 | US20090214511 Digestible compositions of inulin for managing blood glucose levels |
| 08/27/2009 | CA2752868A1 Treatment of energy utilization disease |
| 08/27/2009 | CA2716332A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2716330A1 Compounds and compositions as modulators of gpr119 activity |
| 08/27/2009 | CA2715947A1 Heterocyclic inhibitors of stearoyl-coa desaturase |
| 08/27/2009 | CA2715665A1 Microparticle and pharmaceutical composition thereof |
| 08/27/2009 | CA2715128A1 Anti-obesity compositions comprising orlistat and various natural products |
| 08/27/2009 | CA2714703A1 Compounds and compositions as modulators of gpr119 activity |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2092055A1 Novel vitamin d2 yeast preparation, a method for producing the same, and the use thereof |
| 08/26/2009 | EP2091970A2 Inhibition of platelet aggregation |
| 08/26/2009 | EP2091915A1 Novel diphenylazetidinone substituted by piperazine-1-sulfonic acid having improved pharmacological properties |
| 08/26/2009 | EP2091544A2 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 08/26/2009 | EP2091535A1 Use of pkc inhibitors in transplantation |
| 08/26/2009 | EP2091534A1 Azetidinone derivatives and methods of use thereof |
| 08/26/2009 | EP2091531A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 08/26/2009 | EP1701947B1 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 08/26/2009 | EP1590338B1 Modulators of melanocortin receptor |
| 08/26/2009 | EP1524270B1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN101516877A 杂环有机化合物 Heterocyclic compounds |
| 08/26/2009 | CN101516872A Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 08/26/2009 | CN101516842A A crystalline form B4 of atorvastatin magnesium and a process thereof |
| 08/26/2009 | CN101516826A Beta-3 receptor ligands and their use in therapy |
| 08/26/2009 | CN101516450A Use of quinoa extract as cosmetic and pharmaceutic slimming agent and/or as an agent preventing the formation of new fats in the human body |
| 08/26/2009 | CN101516402A Gel type enteric nutrient |
| 08/26/2009 | CN101516381A Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same |
| 08/26/2009 | CN101514234A Blackfungus polyhexose extraction method |
| 08/26/2009 | CN101514223A Method for preparation of site-specific protein conjugates |
| 08/26/2009 | CN101514159A Compound for preventing and treating diabetes, synthetic preparation method and drug application thereof |
| 08/26/2009 | CN101513533A Method for building models of various diseases in one rat body and application thereof |
| 08/26/2009 | CN101513529A W/O type micro emulsion carrier for insulin injection and preparation method thereof |
| 08/26/2009 | CN101513505A Capsule used for curing cardiovascular and cerebrovascular diseases |
| 08/26/2009 | CN101513501A Composition capable of comprehensively restoring cardio and cerebral circulation systems and preparation method thereof |
| 08/26/2009 | CN101513497A Method for preparing antifat decoction |
| 08/26/2009 | CN101513492A Chinese medicament for treating diabetes |
| 08/26/2009 | CN101513475A Method for preparing antifat traditional Chinese medicine |
| 08/26/2009 | CN101513474A Chinese medicinal oral liquid for treating diabetes |
| 08/26/2009 | CN101513450A Pharmaceutical composition for preventing and treating chronic complicating diseases of diabetes |
| 08/26/2009 | CN101513442A Capsule used for curing diabetes |
| 08/26/2009 | CN101513429A Composition capable of improving blood and sugar metabolism function and preparation method thereof |
| 08/26/2009 | CN101513405A Use of chemotherapeutic agents |
| 08/26/2009 | CN101513394A Continuous preparation method for nanometer dispersed vitamin A microcapsule |
| 08/26/2009 | CN101513389A Oral puerarin nano suspension for improving bioavailability of puerarin |
| 08/26/2009 | CN100532395C Alpha-glucosan originated from Grifola frondosa sporophore and its preparation process and use |
| 08/26/2009 | CN100532374C Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing same |
| 08/26/2009 | CN100532356C Sodium sulfonate substituted diphenyl heptane compound, and preparation method, and application |
| 08/26/2009 | CN100532349C Preparation of phenols difluoro heptane compound, and its oxidation resistant application |
| 08/26/2009 | CN100531784C Blood fat lowering composition medicine |
| 08/26/2009 | CN100531783C Health-care food for reducing blood sugar on the assistant role and its preparing process |
| 08/26/2009 | CN100531739C Use of carbon-2-modified-19-nor-vitamin D analogs to induce the formation of new bone |
| 08/26/2009 | CN100531730C Nateglinide-containing hydrophilic pharmaceutical preparation |
| 08/26/2009 | CN100531729C Composition containing fibrate drug and taurine |
| 08/26/2009 | CN100531600C Hypoglycemic reaction compositions |
| 08/26/2009 | CN100531587C A processing method of ginkgo flower tea |
| 08/26/2009 | CN100531584C Fat-control tea |
| 08/25/2009 | US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia |
| 08/25/2009 | US7579449 Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia |
| 08/25/2009 | US7579369 CB 1 receptor inverse agonists |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system |
| 08/25/2009 | US7579348 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579339 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 08/25/2009 | CA2474578C Novel pyridin- and pyrimidin-derivatives |
| 08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
| 08/20/2009 | WO2009102805A1 Indole compounds and methods of use thereof |
| 08/20/2009 | WO2009102467A2 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/20/2009 | WO2009102460A2 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/20/2009 | WO2009102226A1 Malonic acid salt of 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- 2,4-thiazolidinedione |
| 08/20/2009 | WO2009101959A1 Novel compound, lachnochromonin compound |
| 08/20/2009 | WO2009101956A1 Novel substance fki-3864 and method for production thereof |
| 08/20/2009 | WO2009101917A1 Bicycloamine derivative |
| 08/20/2009 | WO2009101698A1 Composition and method for suppressing fat accumulation |
| 08/20/2009 | WO2009101453A1 Compositions and methods of cure and prophylaxis of hiv/aids and related syndromes |
| 08/20/2009 | WO2009101165A1 Composition for absorption through mucous tissue |
| 08/20/2009 | WO2009101136A1 Treating hyperglycemia with 25-hydroxyvitamin d3 |
| 08/20/2009 | WO2009100970A1 Administration form containing preparations made of solanum melongena and cynara scolymus |
| 08/20/2009 | WO2009100936A2 Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds, and the use thereof |
| 08/20/2009 | WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/20/2009 | WO2009100605A1 A pharmaceutical composition for treating diabetes and preparation methods thereof |
| 08/20/2009 | WO2009071668A3 Piperazine derivatives and their use as leptin receptor modulators |
| 08/20/2009 | WO2009069983A3 A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate |
| 08/20/2009 | WO2009068246A3 Methods of treating obesity and metabolic disorders |
| 08/20/2009 | WO2009059048A3 (+)-opioids and methods of use |
| 08/20/2009 | WO2009046872A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009043354A3 Combination treatment for the treatment of hepatitis c virus infection |
| 08/20/2009 | WO2009033808A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033789A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033765A3 Use of a peptide as a therapeutic agent |